Literature DB >> 8982705

Effects of dantrolene sodium on intracellular Ca2(+)-handling in normal and Ca2(+)-overloaded cardiac muscle.

A Meissner1, G Szymanska, J P Morgan.   

Abstract

We investigated the effects of dantrolene sodium on intracellular Ca2+ homeostasis in normal and Ca2+ overloaded rat cardiac muscle. In isometrically contracting rat papillary muscles loaded with the Ca2+ indicator aequorin, dantrolene (50 microM) produced a mild negative inotropic effect (28 +/- 1.8 to 21 +/- 1.1 mN/mm2; mean +/- S.E.; n = 6; P < 0.01), which was paralleled by a decrease in peak systolic [Ca2+]i (0.81 +/- 0.04 to 0.67 +/- 0.04 microM; P < 0.01). In isolated cardiac sarcoplasmic reticulum, dantrolene (50 microM) increased the initial Ca2+ uptake rate by 23% as compared to control preparations (at pCa 6.2: 46.9 +/- 1.6 to 61.1 +/- 2.2 nmol/mg per min; n = 4; P < 0.001). Intracellular Ca2+ overload was provoked in isoproterenol-pretreated (100 microM) preparations with [Ca2+]o = 5.0 mM at a stimulation rate of 1.0 Hz (n = 12). Diastolic Ca2+ oscillations and aftercontractions increased mean diastolic [Ca2+]i (0.33 +/- 0.1 to 0.56 +/- 0.1 microM) and tension (9.5 +/- 1.8 to 15.3 +/- 2.1 mN/mm2), respectively. Addition of dantrolene (50 microM) reduced the amplitude of Ca2+ oscillations and aftercontractions; mean diastolic [Ca2+]i decreased to 0.44 +/- 0.1 microM and diastolic tension to 13.5 +/- 2.2 mN/mm2. We conclude, therefore, that dantrolene sodium modifies Ca2+ handling by the myocardial sarcoplasmic reticulum, an effect that might be useful in cardiac disorders with impaired [Ca2+]i homeostasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982705     DOI: 10.1016/s0014-2999(96)00678-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Mechanisms underlying hypothermia-induced cardiac contractile dysfunction.

Authors:  Young-Soo Han; Torkjel Tveita; Y S Prakash; Gary C Sieck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-18       Impact factor: 4.733

2.  Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.

Authors:  Shigeki Kobayashi; Masafumi Yano; Takeshi Suetomi; Makoto Ono; Hiroki Tateishi; Mamoru Mochizuki; Xiaojuan Xu; Hitoshi Uchinoumi; Shinichi Okuda; Takeshi Yamamoto; Noritaka Koseki; Hiroyuki Kyushiki; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094

3.  Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice.

Authors:  Mohammed Ali Azam; Praloy Chakraborty; Mahmoud M Bokhari; Keith Dadson; Beibei Du; Stéphane Massé; Daoyuan Si; Ahmed Niri; Arjun K Aggarwal; Patrick F H Lai; Sheila Riazi; Filio Billia; Kumaraswamy Nanthakumar
Journal:  Heart Rhythm O2       Date:  2021-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.